Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficiency of Art-therapy in Psychotic Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02383095
Recruitment Status : Recruiting
First Posted : March 9, 2015
Last Update Posted : October 17, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
The main purpose of the protocol is to test the efficiency of art-therapy versus metacognitive rehabilitation on the visual perception disorders observed in patients with schizophrenia.

Condition or disease Intervention/treatment Phase
Schizophrenia Behavioral: Art therapy Behavioral: metacognitive therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficiency of Art-therapy in Psychotic Disorders
Actual Study Start Date : May 27, 2015
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Art-therapy
16 Art-therapy sessions
Behavioral: Art therapy
Active Comparator: Metacognitive therapy
16 Metacognitive therapy sessions
Behavioral: metacognitive therapy



Primary Outcome Measures :
  1. Change in Response times between baseline and after 16 therapy sessions [ Time Frame: Baseline and after 16 therapy sessions (up to 6 months) ]

Secondary Outcome Measures :
  1. Change in Clinical scales (SAPS and SANS) between baseline and after 16 therapy sessions [ Time Frame: Baseline and after 16 therapy sessions (up to 6 months) ]
  2. Change in esthetic perception between baseline and after 16 therapy sessions [ Time Frame: Baseline and after 16 therapy sessions (up to 6 months) ]
    Esthetic Perception Test

  3. Change in errors in visual organization tasks between baseline and after 16 therapy sessions [ Time Frame: aseline and after 16 therapy sessions (up to 6 months) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia according to DSM IV

Exclusion Criteria:

  • addiction problem
  • invalidating visual sensory problems
  • neurological history

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02383095


Contacts
Layout table for location contacts
Contact: Anne GIERSCH, PhD +33388116471 giersch@unistra.fr

Locations
Layout table for location information
France
Service de psychiatrie, Hôpitaux Universitaires de Strasbourg Recruiting
Strasbourg, France, 67091
Contact: Anne GIERSCH, PhD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Principal Investigator: Anne GIERSCH, PhD Hôpitaux Universitaires de Strasbourg

Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT02383095     History of Changes
Other Study ID Numbers: 5937
First Posted: March 9, 2015    Key Record Dates
Last Update Posted: October 17, 2018
Last Verified: October 2018

Keywords provided by University Hospital, Strasbourg, France:
Schizophrenia
Art-therapy
Visual organization

Additional relevant MeSH terms:
Layout table for MeSH terms
Schizophrenia
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders